Vimentin expression in cervical carcinomas: Association with invasive and migratory potential

Journal of Pathology

Volumn 180, Issue 2, 1996, Pages 175-180

  Gilles, Christine ^a,c   Polette, Myriam ^b,d   Piette, Jacques ^a   Delvigne, Anne Catherine ^a   Thompson, Erik W ^c   Foidart, Jean Michel ^a   Birembaut, Philippe ^b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b HÔPITAL MAISON BLANCHE   (France)

^c GEORGETOWN UNIVERSITY   (United States)

^d INSERM   (France)

Author keywords

cervical carcinoma; invasion; metastasis; migration; vimentin

Indexed keywords

VIMENTIN;

ARTICLE; CANCER INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METASTASIS; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA;

ANIMALS; CARCINOMA IN SITU; CELLS, CULTURED; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; UTERINE CERVICAL NEOPLASMS; VIMENTIN;

EID: 0029804487     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199610)180:2<175::AID-PATH630>3.0.CO;2-G     Document Type: Article

References (37)

1. Gilles C, Pette J, Peter W, Fusenig NE, Foidart J-M. Differentiation ability and oncogenic potential of HPV-33 or HPV-33+ras-transfected keratinocytes. Int J Cancer 1994; 58: 847-854.
2. Gilles C, Polette M, Piette J, Birembaut P, Foidart J-M. Epithelial-to-mesenchymal transition in HPV-33-transfected cervical keratinocytes is associated with increased invasiveness and expression of gelatinase A. Int J Cancer 1994; 59: 661-666.
3. Osborn M, Debus E, Weber K. Monoclonal antibodies specific for vimentin. Eur J Cell Biol 1984; 34: 137-143.
4. Franke WW, Schmid E, Winter S, Osborn M, Weber K. Widespread occurrence of intermediate-sized filaments of the vimentin-type in cultured cells from diverse vertebrates. Exp Cell Res 1979; 123: 25-46.
5. Virtanen I, Lehto VP, Lehtonen E, et al. Expression of intermediate filaments in cultured cells. J Cell Biol 1981; 50: 45-63.
6. Sommers C, Walker-Jones D, Heckford SE, et al. Vimentin rather than keratin expression in some hormone-independent breast cancer cell lines and in oncogene-transformed mammary epithelial cells. Cancer Res 1989; 49: 4258-4263.
7. Thompson EW, Paik S, Brunner N, et al. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol 1992; 150: 534-544.
8. Sommers CL, Byers SW, Thompson EW, Torri J, Gelmann EP. Differentiation state and invasiveness of human breast cancer cell lines. Breast Cancer Res Treat 1994; 31: 325-335.
9. Azumi N, Battifora H. The distribution of vimentin and keratin in epithelial and nonepithelial neoplasms. Am J Clin Pathol 1987; 188: 286-296.
10. Miettinen M, Lehto V-P, Virtanen I. Expression of intermediate filaments in normal ovaries and ovarian epithelial, sex cord stromal, and germinal tumors. Int J Gynaecol Pathol 1983; 2: 64-71.
11. Miettenen M, Franssila K, Lehto V-P, Paasivuo R, Virtanen I. Expression of intermediate filament proteins in thyroid gland and in thyroid tumors. Lab Invest 1984; 50: 262-270.
12. McNutt MA, Bolen JW, Gown AM, Hammar SP, Vogel AM. Co-expression of intermediate filaments in human epithelial neoplasms. Ultrastruct Pathol 1985; 9: 31-43.
13. Gatter KC, Dunnill MS, Van Muijen GNP, Mason DY. Human lung tumors may coexpress different classes of intermediate filaments. J Clin Pathol 1986; 39: 950-954.
14. Upton MP, Hirohashi S, Tome Y, Miyazawa N, Suemasu K, Shimosato Y. Expression of vimentin in surgically resected adenocarcinomas and large cell carcinomas of lung. Am J Surg Pathol 1986; 10: 560-567.
15. Benjamin E, Law S, Bobrow LG. Intermediate filaments cytokeratin and vimentin in ovarian sex cord-stromal tumors with correlative studies in adult and foetal ovaries. J Pathol 1987; 152: 253-263
16. Buley ID, Gatter KC, Heryet A, Mason DY. Expression of intermediate filament proteins in normal and diseased thyroid glands. J Clin Pathol 1987; 40: 136-142.
17. Dogliono C, Dell'orto P, Coggi G, Iuzzolino P, Bontempini L. Choroid plexus tumors. An immunocytochemical study with particular reference to the coexpression of intermediate filament proteins. Am J Pathol 1987; 127: 519-529.
18. Ikegawa S, Saida T, Takizawa Y, et al. Vimentin-positive squamous cell carcinoma arising in a burn scar. Arch Dermatol 1989; 125: 1672-1676.
19. Raymond WA, Leong ASY. Vimentin - a new prognostic parameter in breast carcinoma? J Pathol 1989; 158: 107-114.
20. Domagala W, Lasota J, Bartowiak J, Weber K, Osborn M. Vimentin is preferentially expressed in human breast carcinoma with low oestrogen receptor and high Ki-67 growth fraction. Am J Pathol 1990; 136: 219-227.
21. Domagala W, Leszek W, Lasota J, Weber K, Osborn M. Vimentin is preferentially expressed in high grade ductal and medullary, but not in lobular breast carcinoma. Am J Pathol 1990; 137: 1059-1064.
22. Gould VE, Kouloulis GK, Jansson DS, Nagle RB, Franke WW, Moll R. Coexpression patterns of vimentin and glial filament protein with cytokeratins in the normal, hyperplastic, and neoplastic breast. Am J Pathol 1990; 137: 1143-1115.
23. Raymond WA, Leong ASY. Coexpression of cytokeratin and vimentin intermediate filament proteins in benign and neoplastic breast epithelium J Pathol 1989; 157: 299-306.
24. Wada T, Yasutomi M, Hashmura K, Kunikata M, Tanaka T, Mori M. Vimentin expression in benign and malignant lesions in the human mammary gland. Anticancer Res 1992; 122: 1973-1982.
25. Heatley M, Whiteside C, Maxwell P, Toner P. Vimentin in benign and malignant breast epithelium. J Clin Pathol 1993; 46: 441-445.
26. Domagala W, Striker G, Szadowska A, Dukowicz A, Harezga B, Osborn M. p53 protein and vimentin in invasive ductal NOS breast carcinoma- relationship with survival and sites of metastases. Eur J Cancer 1994; 30A: 1527-1534.
27. Bell CD, Tiscler EM, Laroye GJ. The relationship of cytoplasmic intermediate filaments and membrane antigens with hormone receptors, nuclear staining density, and mode of stromal invasion in human breast cancer. Breast Cancer Res Treat 1995; 33: 147-162.
28. Cattoretti G, Andreola S, Clemente C, D'Amato L, Rilke F. Vimentin and p53 expression on epidermal growth factor receptor-positive, oestrogen receptor-negative breast carcinomas. Br J Cancer 1988; 57: 353-357.
29. Ramaekers FCS, Haag D, Kant A, Moesker O, Jap PHK, Vooijs GP. Coexpression of keratin- and vimentin-type intermediate filaments in human metastatic carcinoma cells. Proc Natl Acad Sci USA 1983; 80: 2618-2622.
30. SundarRaj N, Rizzo JD, Anderson SC, Gesiotto JP. Expression of vimentin by rabbit corneal epithelial cells during wound repair. Cell Tissue Res 1992; 267: 347-356.
31. Thiery JP, Duband JL, Tucker GC. Cell migration in the vertebrate embryo: role of cell adhesion and tissue environment in pattern formation. Annu Rev Cell Biol 1985; 110: 91-113.
32. Boyer B, Tucker GC, Valles AM, Franke WW, Thiery JP. Rearrangements of desmosomal and cytosketal proteins during the transition from epithelial to fibroblastoid organization in cultured rat bladder carcinoma cells. J Cell Biol 1989; 109: 1495-1509.
33. Bae S-N, Arand G, Azzam H, et al. Molecular and cellular analysis of basement membrane invasion by human breast cancer cells in matrigel-based in votro assays. Breast Cancer Res Treat 1993; 24: 241-255.
34. Guarino M. Epithelial-to-mesenchymal change of differentiation. From embryogenetic mechanism to pathological patterns. Histol Histopathol 1995; 10: 171-184.
35. Screenan JJ, Hart WR. Carcinosarcomas of the female genital tract. A pathologic study of 29 metastatic tumors: further evidence for the dominant role of the epithelial component and the conversion theory of histogenesis. Am J Surg Pathol 1995; 6: 666-674.
36. Valles AM, Boyer B, Badet J, Tucker GC, Barritault D, Thiery JP. Acidic fibroblast growth factor is a modulator of epithelial plasticity in a rat bladder carcinoma cell line. Proc Natl Acad Sci USA 1990; 87: 1124-1128.
37. Savagner P, Valles AM, Jouanneau J, Yamada KM, Thiery JP. Alternative splicing in fibroblast growth factor receptor 2 is associated with induced epithelial-mesenchymal transition in rat bladder carcinoma cells. Mol Biol Cell 1994; 5: 851-862.